Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
| Author | :
|
|---|---|
| Abstract | :
Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options for preventing HIV infection. |
| Year of Publication | :
2021
|
| Journal | :
The New England journal of medicine
|
| Volume | :
385
|
| Issue | :
7
|
| Number of Pages | :
595-608
|
| Date Published | :
2021
|
| ISSN Number | :
0028-4793
|
| URL | :
https://www.nejm.org/doi/10.1056/NEJMoa2101016?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
|
| DOI | :
10.1056/NEJMoa2101016
|
| Short Title | :
N Engl J Med
|
| Download citation |